Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 210/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Fondaparinux |
CAS | 114870-03-0 |
MF | C31H43N3NaO49S8 |
MW | 1728.18 |
Purity | 99% |
Appearance | Off-white Powder |
Shelf life | 2 years |
Storage | Cool and dry place |
1. Prevention and help deep vein thrombosis: Fondaparinux can be used to prevent the formation of deep vein thrombosis (DVT), especially when patients are bedridden for a long time, after surgery or have other risks of thrombosis.
2. Prevention and help pulmonary embolism: Fondaparinux can also be used to prevent the occurrence of pulmonary embolism (PE), especially in high-risk groups.
3. Thrombosis prevention in patients with heart disease: Fondaparinux can be used to prevent thrombosis in patients with non-ST-segment elevation myocardial infarction or heart failure.
Capsaicin | Mebendazole | Denatonium Benzoate | Sulforaphane |
Sulbutiamine | Levamisole hcl | Chlortetracycline hcl | Pyrethrins |
Veliparib | Acetyl L-Carnitine | Spinosyn | Lutein |
Nitenpyram | Praziquantel | Fenbendazole | Chlortetracycline HCL |
Paracetamol | Lufenuron | L-carnitine | L-Carnitine Bitartrate |
Flubendazole | Triclobendazole | 3-indole Acetic Acid | Toltrazuril |